A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface

Abstract Dengue virus (DENV), which consists of four serotypes (DENV1‐4), infects over 400 million people annually. Previous studies have indicated most human monoclonal antibodies (HMAbs) from dengue patients are cross‐reactive and poorly neutralizing. Rare neutralizing HMAbs are usually serotype‐s...

Full description

Bibliographic Details
Main Authors: Guntur Fibriansah, Joanne L Tan, Scott A Smith, Adamberage R deAlwis, Thiam‐Seng Ng, Victor A Kostyuchenko, Kristie D Ibarra, Jiaqi Wang, Eva Harris, Aravinda deSilva, James E Crowe Jr, Shee‐Mei Lok
Format: Article
Language:English
Published: Wiley 2014-03-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.1002/emmm.201303404
id doaj-5a2bbed09b4a44cd9ed0e1bdfbeffee2
record_format Article
spelling doaj-5a2bbed09b4a44cd9ed0e1bdfbeffee22021-08-02T10:24:29ZengWileyEMBO Molecular Medicine1757-46761757-46842014-03-016335837110.1002/emmm.201303404A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surfaceGuntur Fibriansah0Joanne L Tan1Scott A Smith2Adamberage R deAlwis3Thiam‐Seng Ng4Victor A Kostyuchenko5Kristie D Ibarra6Jiaqi Wang7Eva Harris8Aravinda deSilva9James E Crowe Jr10Shee‐Mei Lok11Program in Emerging Infectious Diseases Duke–NUS Graduate Medical School Singapore City SingaporeProgram in Emerging Infectious Diseases Duke–NUS Graduate Medical School Singapore City SingaporeDepartment of Medicine Vanderbilt University Nashville TN USADepartment of Microbiology and Immunology University of North Carolina School of Medicine Chapel Hill NC USAProgram in Emerging Infectious Diseases Duke–NUS Graduate Medical School Singapore City SingaporeProgram in Emerging Infectious Diseases Duke–NUS Graduate Medical School Singapore City SingaporeDivision of Infectious Diseases and Vaccinology School of Public Health University of California Berkeley CA USAProgram in Emerging Infectious Diseases Duke–NUS Graduate Medical School Singapore City SingaporeDivision of Infectious Diseases and Vaccinology School of Public Health University of California Berkeley CA USADepartment of Microbiology and Immunology University of North Carolina School of Medicine Chapel Hill NC USAThe Vanderbilt Vaccine Center Vanderbilt University Nashville TN USAProgram in Emerging Infectious Diseases Duke–NUS Graduate Medical School Singapore City SingaporeAbstract Dengue virus (DENV), which consists of four serotypes (DENV1‐4), infects over 400 million people annually. Previous studies have indicated most human monoclonal antibodies (HMAbs) from dengue patients are cross‐reactive and poorly neutralizing. Rare neutralizing HMAbs are usually serotype‐specific and bind to quaternary structure‐dependent epitopes. We determined the structure of DENV1 complexed with Fab fragments of a highly potent HMAb 1F4 to 6 Å resolution by cryo‐EM. Although HMAb 1F4 appeared to bind to virus and not E proteins in ELISAs in the previous study, our structure showed that the epitope is located within an envelope (E) protein monomer, and not across neighboring E proteins. The Fab molecules bind to domain I (DI), and DI‐DII hinge of the E protein. We also showed that HMAb 1F4 can neutralize DENV at different stages of viral entry in a cell type and receptor dependent manner. The structure reveals the mechanism by which this potent and specific antibody blocks viral infection.https://doi.org/10.1002/emmm.201303404cryoEMdengue virushuman antibodyneutralizationstructure
collection DOAJ
language English
format Article
sources DOAJ
author Guntur Fibriansah
Joanne L Tan
Scott A Smith
Adamberage R deAlwis
Thiam‐Seng Ng
Victor A Kostyuchenko
Kristie D Ibarra
Jiaqi Wang
Eva Harris
Aravinda deSilva
James E Crowe Jr
Shee‐Mei Lok
spellingShingle Guntur Fibriansah
Joanne L Tan
Scott A Smith
Adamberage R deAlwis
Thiam‐Seng Ng
Victor A Kostyuchenko
Kristie D Ibarra
Jiaqi Wang
Eva Harris
Aravinda deSilva
James E Crowe Jr
Shee‐Mei Lok
A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
EMBO Molecular Medicine
cryoEM
dengue virus
human antibody
neutralization
structure
author_facet Guntur Fibriansah
Joanne L Tan
Scott A Smith
Adamberage R deAlwis
Thiam‐Seng Ng
Victor A Kostyuchenko
Kristie D Ibarra
Jiaqi Wang
Eva Harris
Aravinda deSilva
James E Crowe Jr
Shee‐Mei Lok
author_sort Guntur Fibriansah
title A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
title_short A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
title_full A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
title_fullStr A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
title_full_unstemmed A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
title_sort potent anti‐dengue human antibody preferentially recognizes the conformation of e protein monomers assembled on the virus surface
publisher Wiley
series EMBO Molecular Medicine
issn 1757-4676
1757-4684
publishDate 2014-03-01
description Abstract Dengue virus (DENV), which consists of four serotypes (DENV1‐4), infects over 400 million people annually. Previous studies have indicated most human monoclonal antibodies (HMAbs) from dengue patients are cross‐reactive and poorly neutralizing. Rare neutralizing HMAbs are usually serotype‐specific and bind to quaternary structure‐dependent epitopes. We determined the structure of DENV1 complexed with Fab fragments of a highly potent HMAb 1F4 to 6 Å resolution by cryo‐EM. Although HMAb 1F4 appeared to bind to virus and not E proteins in ELISAs in the previous study, our structure showed that the epitope is located within an envelope (E) protein monomer, and not across neighboring E proteins. The Fab molecules bind to domain I (DI), and DI‐DII hinge of the E protein. We also showed that HMAb 1F4 can neutralize DENV at different stages of viral entry in a cell type and receptor dependent manner. The structure reveals the mechanism by which this potent and specific antibody blocks viral infection.
topic cryoEM
dengue virus
human antibody
neutralization
structure
url https://doi.org/10.1002/emmm.201303404
work_keys_str_mv AT gunturfibriansah apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT joanneltan apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT scottasmith apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT adamberagerdealwis apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT thiamsengng apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT victorakostyuchenko apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT kristiedibarra apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT jiaqiwang apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT evaharris apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT aravindadesilva apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT jamesecrowejr apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT sheemeilok apotentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT gunturfibriansah potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT joanneltan potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT scottasmith potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT adamberagerdealwis potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT thiamsengng potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT victorakostyuchenko potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT kristiedibarra potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT jiaqiwang potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT evaharris potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT aravindadesilva potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT jamesecrowejr potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
AT sheemeilok potentantidenguehumanantibodypreferentiallyrecognizestheconformationofeproteinmonomersassembledonthevirussurface
_version_ 1721233996688392192